Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

PubWeight™: 2.16‹?› | Rank: Top 2%

🔗 View Article (PMID 1637025)

Published in Ann Intern Med on August 15, 1992

Authors

M H Rosove1, P M Brewer

Author Affiliations

1: UCLA School of Medicine.

Associated clinical trials:

Apixaban for the Secondary Prevention of Thromboembolism Among Patients With the AntiphosPholipid Syndrome (ASTRO-APS) | NCT02295475

Articles citing this

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.57

Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ (2008) 2.02

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis (1993) 1.45

Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. CMAJ (2007) 1.29

Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nat Rev Rheumatol (2010) 1.08

Controversies in lupus: nervous system involvement. Ann Rheum Dis (1995) 1.06

Right atrial thrombus mimicking myxoma with pulmonary embolism in a patient with systemic lupus erythematosus and secondary antiphospholipid syndrome. Tex Heart Inst J (2008) 1.06

Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax (2000) 1.05

Antiphospholipid syndrome: an overview. CMAJ (2003) 1.05

Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis (2003) 1.04

The antiphospholipid syndrome. Semin Nephrol (2007) 1.01

PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp Neurol (2013) 0.87

Antiphospholipid syndrome. BMJ (1993) 0.87

Anticardiolipin antibodies and cardiovascular disease. J R Soc Med (1995) 0.86

Sneddon's syndrome: a comprehensive review of the literature. Orphanet J Rare Dis (2014) 0.85

Management of the antiphospholipid syndrome. Auto Immun Highlights (2010) 0.85

Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol (2006) 0.85

Prothrombotic States that Predispose to Stroke. Curr Treat Options Neurol (2002) 0.84

Life-threatening right ventricular thrombosis in association with phospholipid antibodies. Br Heart J (1993) 0.82

Left ventricular thrombi in a patient with the antiphospholipid syndrome. Br Heart J (1995) 0.81

Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol (1998) 0.81

Antiphospholipid Antibody Syndrome. Curr Treat Options Neurol (2000) 0.79

Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis. Syst Rev (2016) 0.77

Controversies in the antiphospholipid syndrome: can we ever stop warfarin? J Autoimmune Dis (2008) 0.77

Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment. Gut (1994) 0.76

Exhausting multiple hemodialysis access failures. Med Arch (2014) 0.76

Intracerebral hemorrhage associated with Sneddon's syndrome: is ischemia-related angiogenesis the cause? Case report and review of the literature. Neuroradiology (2003) 0.75

Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answers. J Autoimmune Dis (2006) 0.75

Long term anticoagulant treatment in the antiphospholipid syndrome. Ann Rheum Dis (1994) 0.75

Antiphospholipid syndrome. J R Soc Med (2002) 0.75

Multiple steno-obstructive vascular lesions and femoral superficial artery dissection in a young Caucasian male with antiphospholipid syndrome. BMJ Case Rep (2009) 0.75

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches. J Immunol Res (2015) 0.75

Bilateral Superficial Femoral Artery Thrombosis in a 15-Year-Old Caucasian Male with Homozygous Prothrombin G20210A Genotype and Associated Antiphospholipid Syndrome. Int J Angiol (2015) 0.75

A case of cerebral infarction associated with positive antiphospholipid antibody in a systemic lupus patient. Korean J Intern Med (1994) 0.75

Anticardiolipin antibodies and cerebral infarction. J Neurol Neurosurg Psychiatry (1994) 0.75

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events? Cureus (2016) 0.75

Recognizing antiphospholipid syndrome. Case report: misdiagnosis delayed treatment. Can Fam Physician (1996) 0.75

Successful Anticoagulation Therapy for Antiphospholipid Syndrome with Mobile Aortic Thrombi. Vasc Specialist Int (2016) 0.75

Antiphospholipid syndrome: a series of surgical emergencies and the current evidence for its management. Ann R Coll Surg Engl (2006) 0.75

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation. Clin Rheumatol (2004) 0.75